Trial Profile
A retrospective analysis to demonstrate the efficacy and safety of pemetrexed and cisplatin combination therapy in non-squamous NSCLC (non-smal-cell lung cancer) patients: Czech experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 08 Dec 2015 New trial record